NIH-funded research Sbir 2 grant

Test to flag essential tremor patients at risk of Parkinson’s progression by detecting phosphorylated alpha-synuclein

Official title: Analysis of Cutaneous Phosphorylated alpha-Synuclein to Identify Patients at Risk of Progressing from Essential Tremor to Parkinson's Disease

Funded at Cnd Life Sciences, INC. · NIH-11401181 · Data updated 2026-11-12

A new test being developed for people with essential tremor to see who might later develop Parkinson’s disease.

More s Disease research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionCnd Life Sciences, INC.
NIH-funded
Lab location1 site (Scottsdale, UNITED STATES)
Project startSeptember 5, 2025
Project endAugust 31, 2028
Funding year2026
Award (this year)$1,012,800
NIH project number5R44NS143486-02
Project IDNIH-11401181 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with essential tremor who are at risk of developing Parkinson’s disease and are candidates for biomarker testing.

Less likely to help

Patients without essential tremor or those not at risk for phenoconversion may not benefit from this test.

What this research studies

This project aims to create and validate a biomarker test that looks for phosphorylated alpha-synuclein in patients with essential tremor to predict if and when they may develop Parkinson’s disease. It uses direct-to-phase II SBIR funding to advance test development and evaluate predictive capability. If successful, the test could help doctors tailor monitoring and treatment plans for those at higher risk.

Why it matters

Potential benefit: If successful, patients with essential tremor could receive earlier guidance and closer monitoring for Parkinson's progression.

How similar studies have gone: Prior studies show phosphorylated alpha-synuclein is associated with Parkinson’s features, but a clinically practical predictive test for ET patients is still being developed.

Where this research is happening

  • Cnd Life Sciences, INC.
    Scottsdale, United States
    Active

Researchers

  • Principal investigator: Gibbons, Christopher H — Cnd Life Sciences, INC.
  • Study coordinator: Gibbons, Christopher H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.